Iqgen-X Pharma Private Limited

Iqgen-X Pharma Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U74999MH2016PTC286716 Incorporated 13 October 2016 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹8.51 Cr
▼ 14.00% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.13 Cr
Issued & subscribed
Open charges
₹2.28 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
34
Latest available

About Iqgen-X Pharma Private Limited

Data last updated: 06 March 2026

Iqgen-X Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 October 2016, the company has been in operation for over 10 years.

Registered with ROC Mumbai under CIN U74999MH2016PTC286716.

Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.13 Cr. It is led by directors including Madhu Hariharan and Mandar Madhukar Kodgule.

Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: A – 165 Ttc Industrial Area Khairane., Navi Mumbai, Maharashtra, India – 400705.

As per the financials filed for FY 2023, the company reported a revenue of ₹8.51 Cr, a decline of 14% compared to the previous year.

The company has a workforce of approximately 34 employees as per the latest available data.

The company is associated with 1 brand - Iqgen-X Pharma. As per MCA filings, the company has open charges of ₹2.28 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website iqgenx.com.

Company Details of Iqgen-X Pharma Private Limited
CIN U74999MH2016PTC286716
Registration Number 286716
Incorporation Date 13 October 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    A – 165 Ttc Industrial Area Khairane., Navi Mumbai, Maharashtra, India – 400705
  • Industry
    Pharma, Drug Formulation & Development
Company report
Iqgen-X Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Iqgen-X Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Iqgen-X Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Iqgen-X Pharma Private Limited

Iqgen-X Pharma Private Limited operates one associated brand: IQGEN-X Pharma. These brands represent Iqgen-X Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Solid and liquid pharmaceutical formulations are manufactured and developed. iqgenx.com

Competitors & Alternatives of Iqgen-X Pharma Private Limited

Brands and companies operating in the same space as Iqgen-X Pharma Private Limited include Evotec, Crown Bioscience, NIH and 7 more.

Competitor Description Location Founded
Evotec Evotec Drug discovery and development services are provided to biopharma sector. Hamburg, Germany, Germany 1993
Crown Bioscience Crown Bioscience Cancer and CVMD drugs are developed using PDX models. Santa Clara, United States, United States 2006
NIH NIH Drug discovery services are provided to the biopharma sector. United States 1887
Domainex Domainex Drug discovery CRO company for epigenetic research and inflammatory diseases Cambridge, United Kingdom, United Kingdom 2001
Alloy Therapeutics Alloy Therapeutics Drug discovery services are provided for therapeutic development. Lexington, United States, United States 2017
STAQ Pharma STAQ Pharma Drug discovery services are provided for pharmaceutical innovation. Denver, United States, United States 2018
Viva Biotech Viva Biotech Drug discovery and development research services are provided. Shanghai, China, China 2006
Qyuns Therapeutics Qyuns Therapeutics Drug development services are provided to the biopharma sector. Taizhou, China, China 2015
Concept Life Sciences Concept Life Sciences International laboratory testing and consultancy in life sciences are offered. Manchester, United Kingdom, United Kingdom 2014
CatSci CatSci Drug discovery services are provided to pharmaceutical clients worldwide. Cardiff, United Kingdom, United Kingdom 2010

Business Activity of Iqgen-X Pharma Private Limited

Iqgen-X Pharma Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Iqgen-X Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Iqgen-X Pharma Private Limited

Iqgen-X Pharma Private Limited is audited by DIPTI TAPARIA & COMPANY for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
DIPTI TAPARIA & COMPANY Locked Locked Locked
Premium access

Complete auditor history for Iqgen-X Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Iqgen-X Pharma Private Limited

Iqgen-X Pharma Private Limited is currently managed by 5 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Madhu Hariharan Director 01 Apr 2017 9 Years 4 Months Current
Mandar Madhukar Kodgule Director 01 Apr 2017 9 Years 4 Months Current
Yogita Mandar Kodgule Director 01 Apr 2017 9 Years 4 Months Current
Yatendra Kumar Director 01 Apr 2017 9 Years 4 Months Current
Parizad Adil Elchidana Additional Director 30 Sep 2021 4 Years 10 Months Current

Financials of Iqgen-X Pharma Private Limited FY 2023 filings available

Iqgen-X Pharma Private Limited reported revenue of ₹8.51 Cr (down 14.00% YoY) for FY 2023.

Revenue · FY 2023
₹8.51 Cr ▼ 14.00%
Premium access

Ten-year financial statements for Iqgen-X Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Iqgen-X Pharma Private Limited

Premium access

Shareholding and ownership data for Iqgen-X Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Iqgen-X Pharma Private Limited

Open charges
₹2.28 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Canara Bank₹2.28 Cr
Latest charge details
DateLenderAmountStatus
28 Jul 2020 Canara Bank ₹28 Lakh Open
25 Sep 2017 Canara Bank ₹2 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Iqgen-X Pharma Private Limited

Iqgen-X Pharma Private Limited has a workforce of 34 employees as of Apr 03, 2024.

Employee count
34
Active EPFO establishments
1
Employee growth
-5.56%
Premium access

Employee and EPFO history for Iqgen-X Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Iqgen-X Pharma Private Limited

Premium access

GST registrations and filing compliance for Iqgen-X Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Iqgen-X Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Iqgen-X Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Iqgen-X Pharma Private Limited

Premium access

MSME payment history for Iqgen-X Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Iqgen-X Pharma Private Limited

Premium access

Corporate group structure for Iqgen-X Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Iqgen-X Pharma Private Limited

Premium access

MCA filings and documents for Iqgen-X Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Iqgen-X Pharma Private Limited

Activity
30 Sep 2023
Iqgen-X Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Activity
31 Mar 2023
Iqgen-X Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai Ii.
Directors
30 Sep 2021
Parizad Adil Elchidana was appointed as a Additional Director on 30 Sep 2021 & has been associated with this company since 4 years 10 months.
Charges
29 Aug 2020
A charge with Canara Bank of Rs. 2.00 Cr registered on 25 Sep 2017 with Charge ID 100135679 was modified on 29 Aug 2020.
Charges
28 Jul 2020
A charge with Canara Bank amounted to Rs. 0.28 Cr with Charge ID 100355277 was registered on 28 Jul 2020.
Charges
25 Sep 2017
A charge with Canara Bank amounted to Rs. 2.00 Cr with Charge ID 100135679 was registered on 25 Sep 2017.

Recent News on Iqgen-X Pharma Private Limited

Frequently Asked Questions about Iqgen-X Pharma Private Limited

Iqgen-X Pharma Private Limited is an active private limited company in the pharma sector based in Navi Mumbai, Maharashtra, India. It was incorporated on 13 October 2016 (10+ years old) and is registered under CIN U74999MH2016PTC286716. The company has 34 employees.

Iqgen-X Pharma Private Limited reported revenue of ₹8.51 Cr for FY 2023 (down 14.00% YoY).

The current directors of Iqgen-X Pharma Private Limited are:

The primary industry of Iqgen-X Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes, Iqgen-X Pharma Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Iqgen-X Pharma Private Limited can be reached at the registered office: A – 165 Ttc Industrial Area Khairane, Navi Mumbai, Maharashtra, India – 400705, or through the website iqgenx.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available